Publications
The Development of a Novel Nanobody Therapeutic for SARS-CoV-2. bioRxiv. 10.1101/2020.11.17.386532
(2020) The development of Nanosota-1 as anti-SARS-CoV-2 nanobody drug candidates. Elife. 10.7554/eLife.64815
(2021) NECAT
9700 S. Cass Ave.
Bldg. 436E
Argonne, IL 60439
630.252.0689
necatinfo@anl.gov
Copyright © 2022, NECAT
Design by FreeBiezz